跳至主要内容
临床试验/NCT05438576
NCT05438576已完成不适用

Screening for Peripartum Cardiomyopathies Using Artificial Intelligence (SPEC-AI) in Nigeria

Mayo Clinic6 个研究点 分布在 1 个国家目标入组 1,232 人开始时间: 2022年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
1,232
试验地点
6
主要终点
Left Ventricular Ejection Fraction (LVEF) <50%

研究概览

简要总结

This study will evaluate the effectiveness of an artificial intelligence-enabled ECG (AI-ECG) for cardiomyopathy detection in an obstetric population in Nigeria.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Currently pregnant or within 12 months postpartum
  • Willing and able to provide informed consent

排除标准

  • Complex congenital heart disease (single ventricle physiology or significant shunts with cardiac structural changes)
  • Significant conduction abnormalities (ventricular pacing on recorded ECG, pacemaker dependence, or severely abnormal/bizarre QRS morphology on ECG tracings)
  • Unable or unwilling to provide consent

结局指标

主要结局

Left Ventricular Ejection Fraction (LVEF) <50%

时间窗: 18 months

Number of participants diagnosed with left ventricular ejection fraction (LVEF) \<50% by echocardiography during pregnancy or within 12 months postpartum.

次要结局

  • Effectiveness of AI-ECG for Cardiomyopathy Detection in the Intervention Arm for Left Ventricular Ejection Fraction (LVEF) ≤ 35%(18 months)
  • Effectiveness AI-ECG for Cardiomyopathy Detection in the Intervention Arm in LVEF < 40%(18 months)
  • Effectiveness AI-ECG for Cardiomyopathy Detection in the Intervention Arm in LVEF < 45%(18 months)
  • Effectiveness AI-ECG for Cardiomyopathy Detection in the Intervention Arm in LVEF < 50%(18 months)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Demilade A. Adedinsewo

Principal Investigator

Mayo Clinic

研究点 (6)

Loading locations...

相似试验

Screening for Pregnancy Related Heart Failure in... | 临床试验